Junjian Wang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- Molecular Biology top 5%
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- Protein Degradation and Inhibitors
Papers in
-
- Epigenetics and DNA Methylation 10
- Histone Deacetylase Inhibitors Research 8
- RNA modifications and cancer 8
- Protein Degradation and Inhibitors 7
- Oncology 19
- Co-authors
- Chi‐Wai Wong (6 shared papers)Jianzhen Xu (9 shared papers)June X. Zou (9 shared papers)Zhijian Duan (7 shared papers)Hong-Wu Chen (9 shared papers)Haibin Wang (7 shared papers)Peiqing Liu (16 shared papers)Zhiyan Huang (2 shared papers)
- Journals
- Cell Biology International (6 papers)Journal of Medicinal Chemistry (6 papers)Acta Pharmaceutica Sinica B (4 papers)Acta Pharmacologica Sinica (4 papers)Cell Death and Differentiation (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Junjian Wang
104 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 560
- Molecular Biology 1.6k
- Oncology 494
- Pulmonary and Respiratory Medicine 428
- Pharmacology 195
Countries citing papers authored by Junjian Wang
This map shows the geographic impact of Junjian Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junjian Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junjian Wang more than expected).
Fields of papers citing papers by Junjian Wang
This network shows the impact of papers produced by Junjian Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junjian Wang. The network helps show where Junjian Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Junjian Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 107 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer Hit paper breakdown → | 2022 | 323 |
| 2 | 2016 | 156 | |
| 3 | 2014 | 143 | |
| 4 | 2020 | 86 | |
| 5 | 2019 | 81 | |
| 6 | 2009 | 73 | |
| 7 | 2016 | 73 | |
| 8 | 2016 | 63 | |
| 9 | 2020 | 54 | |
| 10 | 2020 | 52 | |
| 11 | 2009 | 51 | |
| 12 | 2018 | 49 | |
| 13 | 2021 | 47 | |
| 14 | 2015 | 45 | |
| 15 | 2018 | 45 | |
| 16 | 2009 | 44 | |
| 17 | 2020 | 43 | |
| 18 | 2016 | 41 | |
| 19 | 2010 | 40 | |
| 20 | 2017 | 40 |
About Junjian Wang
Junjian Wang is a scholar working on Molecular Biology, Oncology, Cancer Research, Genetics and Pulmonary and Respiratory Medicine, having authored 107 papers that have together received 2.7k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (10 papers), Epigenetics and DNA Methylation (10 papers), Histone Deacetylase Inhibitors Research (8 papers), RNA modifications and cancer (8 papers), Prostate Cancer Treatment and Research (8 papers), Cancer, Hypoxia, and Metabolism (7 papers), Protein Degradation and Inhibitors (7 papers) and Microbial Natural Products and Biosynthesis (7 papers). The work is most often cited by research in Cancer Research (560 citations), Molecular Biology (1.6k citations), Oncology (494 citations), Pulmonary and Respiratory Medicine (428 citations) and Pharmacology (195 citations). Junjian Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Chi‐Wai Wong, Jianzhen Xu, June X. Zou, Zhijian Duan, Hong-Wu Chen, Haibin Wang, Peiqing Liu, Zhiyan Huang, Fang Fang and Jian Jian Li. Their work appears in journals such as Cell Biology International, Journal of Medicinal Chemistry, Acta Pharmaceutica Sinica B, Acta Pharmacologica Sinica and Cell Death and Differentiation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.